ChemoCentryx, Inc. Debt Securities, Available-for-sale, Current
ChemoCentryx, Inc. had Debt Securities, Available-for-sale, Current of $284.22 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2022-08-08
- 2022-06-30: Debt Securities, Available-for-sale, Current $284.22M.
- 2022-03-31: Debt Securities, Available-for-sale, Current $300.02M.
- 2021-12-31: Debt Securities, Available-for-sale, Current $214.51M.
- 2021-09-30: Debt Securities, Available-for-sale, Current $175.70M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2022-06-30 | $284.22M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $300.02M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $214.51M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $175.70M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $235.40M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $307.74M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $404.27M 10-K · filed 2022-03-01 |
| 2020-09-30 | $415.21M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $171.41M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $124.25M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $133.61M 10-K · filed 2021-03-01 |
| 2019-09-30 | $135.01M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $160.61M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $142.78M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $148.90M 10-K · filed 2020-03-10 |
| 2018-09-30 | $149.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $113.29M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $116.02M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $87.27M 10-K · filed 2019-03-11 |
| 2017-09-30 | $102.60M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $100.14M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $99.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $105.74M 10-K · filed 2018-03-12 |
| 2016-09-30 | $107.73M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $103.78M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $50.77M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $58.45M 10-K · filed 2017-03-14 |